No Data
No Data
Japan Approves BridgeBio Pharma-AstraZeneca Partnered Rare Heart Disease Drug
Genmab and BridgeBio Pharma Announce Japan Approval for Their Treatments
BridgeBio Pharma Says Beyonttra Approved in Japan to Treat Heart Condition
Express News | BridgeBio Pharma- Will Receive a $30 Mln Milestone Payment Upon Approval in Japan
Express News | Beyonttra™ (Acoramidis), the First Near-Complete Ttr Stabilizer (≥90%), Approved in Japan to Treat Attr-Cm
BridgeBio Pharma Is Maintained at Overweight by JP Morgan
SteadyBoomBeepBeep : wow you’re the only one here